Tuesday, June 2, 2020

COVID-19 drug | No approval yet for Indian companies to market remdesivir: Report

COVID-19 drug | No approval yet for Indian companies to market remdesivir: Report It is the only drug so far that has shown significant effect on patients infected with COVID-19.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-drug-|-no-approval-yet-for-indian-companies-to-market-remdesivir-report_13853361.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

GMR Airports shares rise 3% as company swings to black with Rs 202 crore profit in Q3

GMR Airports share price: GMR Airports shares gained 3% on news of significant profit for Q3 FY25, driven by increased passenger traffic and...